Serotonin Syndrome Following Methylene Blue Administration for Vasoplegic Syndrome

Journal of Cardiac Surgery

Volumn 31, Issue 4, 2016, Pages 208-210

  Hencken, Laura ^a   To, Long ^a   Ly, Nancy ^a   Morgan, Jeffrey A ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CITALOPRAM; HYPERTENSIVE FACTOR; METHYLENE BLUE; MILRINONE; NORADRENALIN; PETHIDINE; PHENYLEPHRINE; PROPOFOL; SEROTONIN UPTAKE INHIBITOR;

ADULT; AORTA CLAMPING; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; ATRIAL FIBRILLATION; BLOOD CLOTTING DISORDER; CASE REPORT; CLONUS; CONTINUOUS INFUSION; DEPRESSION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG WITHDRAWAL; EYE MOVEMENT DISORDER; FASCICULATION; FEMALE; FEVER; HEART CATHETERIZATION; HEART FAILURE; HUMAN; HYPERREFLEXIA; HYPOTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT VENTRICULAR ASSIST DEVICE; MEDICAL HISTORY; MUSCLE HYPERTONIA; MYDRIASIS; NEUROLOGIC EXAMINATION; NEW YORK HEART ASSOCIATION CLASS; NONISCHEMIC CARDIOMYOPATHY; OPERATION DURATION; OPSOCLONUS; POSTOPERATIVE COMPLICATION; SEDATION; SEROTONIN SYNDROME; SHIVERING; SYMPTOM; TREATMENT WITHDRAWAL; TREMOR; VASOPLEGIA; CHEMICALLY INDUCED; DRUG POTENTIATION; HEART ASSIST DEVICE; MIDDLE AGED; PROSTHESIS IMPLANTATION; SEVERITY OF ILLNESS INDEX;

CITALOPRAM; DRUG SYNERGISM; FEMALE; HEART-ASSIST DEVICES; HUMANS; METHYLENE BLUE; MIDDLE AGED; PROSTHESIS IMPLANTATION; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; VASOPLEGIA;

EID: 84959528246     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/jocs.12705     Document Type: Article

References (8)

1. Levin RL, Degrange MA, Bruno GF, et al,: Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 2004; 77 (2): 496-499.
2. Levin MA, Lin HM, Castillo JG, et al,: Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome. Circulation 2009; 120 (17): 1664-1671.
3. Lenglet S, Mach F, Montecucco F,: Methylene blue: Potential use of an antique molecule in vasoplegic syndrome during cardiac surgery. Expert Rev Cardiovasc Ther 2011; 9: 1519-1525.
4. Fischer GW, Levin MA,: Vasoplegia during cardiac surgery: Current concepts and management. Semin Thoracic Surg 2010; 22: 140-144.
5. Dunkley EJC, Isbister GK, Sibbritt D, et al,: The Hunter Serotonin Toxicity Criteria: Simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96: 635-642.
6. Boyer EW, Shannon M,: The serotonin syndrome. NEJM 2005; 352: 1112-1120.
7. Food and Drug Administration: FDA drug safety communication: Updated information about the drug interaction between methylene blue (methylthioninium chloride) and serotonergic psychiatric medications. 2011. Available from http://www.fda.gov/Drugs/DrugSafety/ucm276119.htm Accessed April 25, 2015.
8. Grubb KJ, Kennedy JL, Bergin JD, et al,: The role of methylene blue in serotonin syndrome following cardiac transplantation: A case report and review of the literature. J Thorac Cardiovasc Surg 2012; 144: e113-e116.